Epiomic Epidemiology Series Reports
In order to provide a more condensed version of our Epiomic Patient segmentation database for our clients, we have developed a new range of reports called the Epiomic Epidemiology Series.
Each of these publications is disease specific and typically covers between 12-15 Major Global Markets with a forecast horizon of 10 years. Each report includes analyst insights about the disease or disorder and provide insight related to:
- cause of the disease
- risk factors and prevention
- variations by geography or ethnicity
- key co morbid conditions associated with the disease
- disease prognosis and clinical course
The majority of the report is presented in easy to understand data tables showing prevalence by specific country across a 10 year horizon period. Each report includes the overall top-line prevalence for the disease in each country along with a split by gender. To add a further level of detail, we have provided a breakdown of the prevalence or incidence population by gender in 5 year cohorts for each country in the appendix section of the report.
A real benefit of using the Epiomic patient segmentation database as a source is its ability to look beyond just the prevalence and incidence rate of a disease, and show clinically relevant sub-populations. These sub-populations can be either key co-morbid conditions or other clinical attributes that help size potential target populations of interest for drug development. All of these sub-populations are included in table format with each population segmented even further by country or other parameters related to the sub-population.
These reports are based on data and information sourced from the Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources to provide the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been cited in the report.